Invest in Israel Newsletter March 2010 Edition
VC Cafe
APRIL 8, 2010
Israel’s central bank, Morgan Stanley and other financial institutions have forecasted 3.5% billion, and in 2005 it bought another generics competitor, Ivax, based in Miami, for about $7.4 US drug powerhouse Pfizer and Iceland-based Actavis were among the bidders in the final round, but Teva beat their offers.
68 
Let's personalize your content